Oral Answers to Questions

George Freeman Excerpts

Thursday 12th February 2015 Commons Chamber

[Mrs Cheryl Gillan (Chesham and Amersham) (Con)]

T5. The Minister responsible for life sciences will be familiar with Daiichi Sankyo, an innovative drug company based in Chesham and Amersham. It is launching a novel oral anticoagulant to help prevent strokes more effectively in people who suffer with atrial fibrillation. The uptake of such drugs has been repeatedly blocked by the NHS despite guidance from the National Institute for Health and Care Excellence that calls for their use. What can the Minister do to clear that blockage so that the drugs can be used to benefit our patients?

[The Parliamentary Under-Secretary of State for Business, Innovation and Skills (George Freeman)]

I am indeed familiar with the great work of Daiichi Sankyo, and that of my right hon. Friend in supporting its investment in her constituency. I recently had the pleasure of going up to open a new facility. She raises an important point, and the appointment of a Minister responsible for life sciences at the Departments for Business, Innovation and Skills and of Health, where I have responsibility for NICE and the Medicines and Healthcare products Regulatory Agency, allows us to begin to ensure that our health system better supports our life sciences cluster. The review I recently launched of speedier access for innovative medicines will tackle the issue of uptake that my right hon. Friend has rightly raised.

[Heidi Alexander (Lewisham East) (Lab)]

T6. Ninety-three per cent. of those aged 25 or over who completed apprenticeships last year already worked for their employer. If this is not just a rebadging of existing training programmes as apprenticeships, what is it?

--- Later in debate ---

[Mr David Willetts (Havant) (Con)]

Will the Minister confirm that one of the best ways of getting funding into innovative life sciences companies is for them to get contracts from the NHS earlier? He just referred to his very important early access review. What are the ambitions for that, and the timetable?

[George Freeman]

My right hon. Friend and predecessor makes an important point. Since we launched the life science strategy at the start of this Parliament, as set out and led by my right hon. Friend, this country has attracted over £3.5 billion of inward investment into the sector and created more than 11,000 jobs, so something is going very right. He makes a key point: the next step is to ensure that our NHS is driving quicker access. We shall shortly be announcing the chair of the review, and we have already started to gather evidence. My right hon. Friend will have noticed on his recent trip to America the support and the interest that it is gaining overseas for driving our sector forward.

[Philip Davies (Shipley) (Con)]

When the Secretary of State’s Department was called the Department of Trade and Industry, he called for it to be abolished, saying:

“The DTI should be wound up because it doesn’t perform a function. It has no real role anymore”.

Interestingly, his solution was not to reform the Department and rename it BIS; his solution was to split the duties of the Department between existing Government Departments —he cited the Department for Work and Pensions and the Department for Education and Skills. Which of his duties does he think should be handled by other Government Departments, or what has changed his mind? Was it a ministerial salary, perhaps?